373 related articles for article (PubMed ID: 7876895)
1. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.
Griffin WS; Sheng JG; Roberts GW; Mrak RE
J Neuropathol Exp Neurol; 1995 Mar; 54(2):276-81. PubMed ID: 7876895
[TBL] [Abstract][Full Text] [Related]
2. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.
Mrak RE; Sheng JG; Griffin WS
J Neuropathol Exp Neurol; 1996 Mar; 55(3):273-9. PubMed ID: 8786385
[TBL] [Abstract][Full Text] [Related]
3. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms.
Sheng JG; Mrak RE; Griffin WS
Acta Neuropathol; 1997 Jul; 94(1):1-5. PubMed ID: 9224523
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression.
Sheng JG; Mrak RE; Griffin WS
Neuropathol Appl Neurobiol; 1996 Aug; 22(4):334-41. PubMed ID: 8875468
[TBL] [Abstract][Full Text] [Related]
5. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
Sheng JG; Mrak RE; Griffin WS
Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597
[TBL] [Abstract][Full Text] [Related]
6. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease.
Sheng JG; Griffin WS; Royston MC; Mrak RE
Neuropathol Appl Neurobiol; 1998 Aug; 24(4):278-83. PubMed ID: 9775393
[TBL] [Abstract][Full Text] [Related]
7. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
Dickson TC; Vickers JC
Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
[TBL] [Abstract][Full Text] [Related]
8. [Expression of cytokine IL-1α and S100β in different types of plaques in Alzheimer's disease].
Yao JJ; He SR; Chen L; Yang L; Qiao XB; Zhang W; Du J; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):581-4. PubMed ID: 22177239
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis.
Sheng JG; Ito K; Skinner RD; Mrak RE; Rovnaghi CR; Van Eldik LJ; Griffin WS
Neurobiol Aging; 1996; 17(5):761-6. PubMed ID: 8892349
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
[TBL] [Abstract][Full Text] [Related]
11. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
Dickson TC; Saunders HL; Vickers JC
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
[TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: an immunohistochemical study.
Gearing M; Wilson RW; Unger ER; Shelton ER; Chan HW; Masters CL; Beyreuther K; Mirra SS
J Neuropathol Exp Neurol; 1993 Jan; 52(1):22-30. PubMed ID: 7678853
[TBL] [Abstract][Full Text] [Related]
13. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
[TBL] [Abstract][Full Text] [Related]
14. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease.
Masliah E; Mallory M; Deerinck T; DeTeresa R; Lamont S; Miller A; Terry RD; Carragher B; Ellisman M
J Neuropathol Exp Neurol; 1993 Nov; 52(6):619-32. PubMed ID: 8229081
[TBL] [Abstract][Full Text] [Related]
15. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
Cras P; Kawai M; Siedlak S; Mulvihill P; Gambetti P; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
Am J Pathol; 1990 Aug; 137(2):241-6. PubMed ID: 2117395
[TBL] [Abstract][Full Text] [Related]
16. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
[TBL] [Abstract][Full Text] [Related]
17. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
Thal DR; Härtig W; Schober R
J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
[TBL] [Abstract][Full Text] [Related]
18. Microglial activation in early stages of amyloid beta protein deposition.
Sasaki A; Yamaguchi H; Ogawa A; Sugihara S; Nakazato Y
Acta Neuropathol; 1997 Oct; 94(4):316-22. PubMed ID: 9341931
[TBL] [Abstract][Full Text] [Related]
19. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease.
Schmidt ML; DiDario AG; Lee VM; Trojanowski JQ
FEBS Lett; 1994 May; 344(1):69-73. PubMed ID: 8181568
[TBL] [Abstract][Full Text] [Related]
20. Neuritic Plaques - Gateways to Understanding Alzheimer's Disease.
Tsering W; Prokop S
Mol Neurobiol; 2024 May; 61(5):2808-2821. PubMed ID: 37940777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
